CHEST
Original Research: Pulmonary Vascular DiseaseDobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation
Section snippets
Subjects
A total of 60 subjects participated in the study. Dobutamine stress echocardiography (DSE) was performed in healthy control subjects (n = 22) and patients with PAH (n = 16). An additional group of healthy control subjects (age- and sex-matched to the healthy control subjects who underwent DSE) who had undergone exercise echocardiography (n = 22) were used as a comparison group to understand any differences in the mPpa-Q relationships during exercise vs dobutamine stress in the normal pulmonary
Results
Baseline characteristics of the study groups are presented in Table 1. Two healthy control subjects and one patient with PAH who had undergone dobutamine stress were excluded from final analysis due to insufficient quality of echocardiographic measurements. The overall success rate for DSE was 93%.
The diagnosis of patients with PAH included idiopathic PAH (n = 6), connective tissue-associated PAH (n = 9), and portopulmonary hypertension (n = 1). Patients with PAH encompassed a range of disease
Discussion
Our study demonstrates that it is feasible to derive meaningful mPpa-Q relationships using dobutamine stress to augment Q to assess the functional state of the pulmonary circulation. Subjects with PAH revealed markedly elevated mPpa-Q slopes compared with healthy control subjects under dobutamine stress. In addition, poor functional class status in patients with PAH was associated with higher dobutamine-induced mPpa-Q slopes. The novel application of DSE for the pulmonary circulation is a
Conclusions
By using dobutamine stress to augment pulmonary flow, multipoint mPpa-Q plots can be generated to noninvasively assess the functional status of the pulmonary circulation. This is potentially more practical than exercise stress echocardiography, and dobutamine stress reveals substantial differences between healthy subjects and those with PAH. Further validation studies are required to determine the potential utility of measuring mPpa-Q response during dobutamine stress for early diagnosis,
Acknowledgments
Author contributions: E. M. T. L. served as principal author, had access to all of the data in the study, and takes responsibility for the integrity of the study data. E. M. T. L., L. R. S., T. J. C., R. N., and D. S. C. contributed to study concept and design; E. M. T. L., R. R. V., P. C., P. A., and M. D. contributed to data collection and analysis; R. N. and D. S. C. contributed to manuscript preparation; E. M. T. L. contributed to the drafting of the manuscript; R. R. V., P. C., L. R. S.,
References (34)
- et al.
Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences
Chest
(2012) - et al.
Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis
J Am Soc Echocardiogr
(2013) - et al.
Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography
J Am Coll Cardiol
(1997) - et al.
Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics
J Am Soc Echocardiogr
(2010) - et al.
New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure
Chest
(2004) - et al.
The usefulness of a 10% air-10% blood-80% saline mixture for contrast echocardiography: Doppler measurement of pulmonary artery systolic pressure
J Am Coll Cardiol
(2002) - et al.
Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine
Lancet
(1974) - et al.
Abnormal left ventricular early diastolic filling during dobutamine stress Doppler echocardiography is a sensitive indicator of significant coronary artery disease
J Am Coll Cardiol
(1994) - et al.
Left ventricular diastolic filling pressures during dobutamine stress echocardiography: relationship to symptoms and ischemia
J Am Soc Echocardiogr
(2009) Pulmonary hypertension with special reference to the vasoconstrictive factor
Br Heart J
(1958)
Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases
Circulation
Pulmonary circulation at exercise
Compr Physiol
ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur Heart J
Exercise-induced pulmonary arterial hypertension
Circulation
Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma
Am J Respir Crit Care Med
Exercise-induced pulmonary hypertension: physiological basis and methodological concerns
Am J Respir Crit Care Med
Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward
Eur Heart J
Cited by (0)
FUNDING/SUPPORT: This study was supported by the National Health and Medical Research Council (NHMRC) of Australia Project [Grant 1022141 to Dr Celermajer and Dr Corte] and a NHMRC and Heart Foundation Postgraduate Scholarship to Dr Lau [No. 633136].
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.